BREAKING: Hims stock, $HIMS, extends losses to -17% on the day as Novo Nordisk says it is suing the company for making knock-offs of its obesity medicines.

From Twitter
Disclaimer: The content above is only the author's opinion which does not represent any position of Followin, and is not intended as, and shall not be understood or construed as, investment advice from Followin.
Like
Add to Favorites
Comments